Roman Vangoitsenhoven is a clinical endocrinologist at UZ Leuven, with a special interest in obesity and type 2 diabetes. His research focusses on the metabolic and neuropsychogical effects of bariatric surgery and antiobesity medication. His work has been awarded by the Belgian Endocrine Society, the Belgian (BASO) and the European Association for the Study of Obesity (EASO, New Investigator Award in Basic Science in 2021) and Novo Nordisk prize for Diabetology in 2024.

I'm an endocrinologist and head of department of endocrinology at ZAS hospitals. Working also in the  Antwerp university hospital. 

Former president of the Belgian Diabetes Liga and board member of the Belgian Lipid Club ( Belgian Atherosclerosis Society)

Special interest for cardiovasculair prevention, lipid disorders and management of Type 2 diabetes.

Philippe van de Borne is Professor of Cardiology at the Université libre de Bruxelles (HUB-Erasme). He completed a Fogarty Fellowship at the National Institutes of Health (USA), where he conducted research on autonomic dysfunction in heart failure. His current work focuses on cardiovascular prevention—including diabetes, hypercholesterolemia, obesity, hypertension, and thrombosis—and on cardiac rehabilitation. A former President of the Belgian Working Group on Cardiovascular Prevention and Rehabilitation of the Belgian Society of Cardiology, he has authored or co-authored 294 publications (H-index 60), received several international awards, and is actively involved in European and Belgian cardiology and hypertension societies.

More information soon

​